Category

Clinical Trials

Søren Bregenholt

Alligator Bioscience presents Phase 1b/2 data

September 14, 2022

Alligator Bioscience has announced a …

parkinsons

Dizlin Pharmaceuticals publishes data from pharmacokinetic study

September 8, 2022

The Gothenburg based company has …

Richard Godfrey

IRLAB’s partner initiates clinical studies

September 7, 2022

IRLAB Therapeutics have announced that …

BioInvent completes dose-escalation in Phase 1/2a trial

September 6, 2022

BioInvent International has announced the …

nerve cells istock

Peer-reviewed research supports TikoMed’s ILB’s mode of action

September 5, 2022

New research shows that ILB …

EpiEndo starts clinical trial with its lead molecule

September 2, 2022

EpiEndo Pharmaceuticals has received regulatory …

New data from AstraZeneca’s Farxiga trials

August 29, 2022

New results from a pre-specified, …

Jeppe Øvlesen

SynAct Pharma’s EXPAND study CTA approved

August 26, 2022

The Clinical Trial Application (CTA) …

PharmNovo starts Phase I study

August 24, 2022

During the summer, the application …

Ultimovacs expands high dose cohort size in Phase I trial

August 19, 2022

Ultimovacs has completed treatment of …

Sarah Fredriksson

Aqilion starts Phase 1 clinical trial

August 15, 2022

The company’s Phase 1 clinical …

Ulf Jungnelius

Isofol announces disappointing trial results

August 15, 2022

Isofol Medical has announced that …

BioInvent enrolls first patient in Phase 1/2a trial

August 8, 2022

BioInvent International has announced treatment …

Mendus publishes preclinical data

July 21, 2022

Mendus has announced the publication …

Nordic Nanovector

Nordic Nanovector to discontinue the PARADIGME trial

July 12, 2022

Nordic Nanovector has provided an …

Pila Pharma initiates toxicological studies

July 5, 2022

Pila Pharma has announced that …

1
2
3
4
···
44